IRVING, Texas— RBC Life Sciences Inc. (OTCBB: RBCL) released the financial results for the first quarter of 2010 (1Q10), ended March 31, 2010. Net sales hit $7.0 million for 1Q10, an increase of 16 percent from the same period in 2009. Net earnings hit $211,000 for the first quarter, compared to a net loss of $171,000 during 1Q09.
“After encountering a tough economic climate in 2009, our international dietary supplements licensee is beginning to see an improving market overseas,” said John W. Price, RBC Life Sciences’ president and CEO. “Domestically, we saw an increase in our medical products customer base while we also continued a number of sales and marketing initiatives designed to offset the first quarter decline in our network marketing independent Associate base.”
The company also recently announced it was certified compliant with federal GMPs (good manufacturing practices) for dietary supplements.
